IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS µL?. Mediterr J Hematol Infect Dis 2019, 11 (1), e2019063. https://doi.org/10.4084/mjhid.2019.063.